The AIDS Beacon » Drug Reimbursement Information

Genentech Access To Care Foundation

Meerat Oza — Tue, 29 Mar 2011 00:35:07 +0000

The Genentech Access To Care Foundation provides Fuzeon (enfuvirtide) and Invirase (saquinavir mesylate) free to qualified patients. To enroll, patients must be uninsured and have an annual adjusted gross household income of less than $100,000.

Egrifta Patient Assistance Program

Meerat Oza — Tue, 29 Mar 2011 00:15:04 +0000

The Egrifta Patient Assistance Program provides Egrifta (tesamorelin) for free to uninsured or under-insured patients who earn less than 600 percent of the federal poverty level. For more information, please call the AXIS Center at 877-714-AXIS (2947).

ViiV Healthcare Patient Assistance Program

Meerat Oza — Tue, 29 Mar 2011 00:08:37 +0000

ViiV Healthcare Patient Assistance Program provides low-income HIV patients with ViiV Healthcare products at little or no cost. ViiV Healthcare manufactures Combivir (zidovudine/lamivudine), Epivir (lamivudine), Epzicom (abacavir/lamivudine), Lexiva (fosamprenavir), Rescriptor (delavirdine), Retrovir (zidovudine), Selzentry (maraviroc), Trizivir (zidovudine/lamivudine/abacavir), Viracept (nelfinavir), and Ziagen (abacavir).

Bristol-Myers Squibb Patient Assistance Programs

Meerat Oza — Mon, 28 Mar 2011 23:58:55 +0000

Bristol-Myers Squibb has three patient assistance programs for people with HIV: Access Virology, the Atripla Patient Assistance Program, and Together Rx Access. Access Virology and Together Rx Access cover Reyataz (atazanavir) and Sustiva (efavirenz); the Atripla Patient Assistance Program Covers Atripla (efavirenz/emtricitabine/tenofovir).

Gilead Patient Assistance Programs

Meerat Oza — Mon, 28 Mar 2011 23:49:05 +0000

Gilead Sciences provides financial assistance to people with HIV through two programs: the U.S. Advancing Access program and the Atripla Patient Assistance Program. The first program covers Emtriva (emtricitabine), Truvada (emtricitabine/tenofovir), and Viread (tenofovir); the second covers Atripla (efavirenz/emtricitabine/tenofovir). Both programs provide assistance to patients who do not have insurance or are otherwise in need of financial assistance to pay for their HIV medications.

Boehringer Ingelheim Cares Foundation Patient Assistance Program

Shruti Kalra — Thu, 13 Aug 2009 02:52:41 +0000

The Boehringer Ingelheim Cares Foundation Patient Assistance Program (BI-PAP) makes Boehringer Ingelheim products available to patients who are without pharmaceutical insurance coverage and who meet certain household income levels. The website helps patients learn about the program and navigate the application process. Boehringer Ingelheim makes Aptivus (tipranavir) and Viramune (nevirapine).

Pfizer Patient Assistance Program

Shruti Kalra — Thu, 13 Aug 2009 02:51:49 +0000

Pfizer offers a patient assistance program for patients who are unable to afford Pfizer medications. The web site helps patients learn about the program and navigate the application process.

Tibotec Therapeutics Patient Assistance Programs

Shruti Kalra — Thu, 13 Aug 2009 02:50:37 +0000

Tibotec Therapeutics offers a patient assistance program that provides HIV medications at no charge. The website helps patients learn about the program and navigate the application process. Tibotec makes Intelence (etravirine) and Prezista (darunavir).

Abbott Patient Assistance Program

Shruti Kalra — Thu, 13 Aug 2009 02:49:23 +0000

Abbott offers a patient assistance program for patients who are unable to afford Abbott medications. The website helps patients learn about the program and navigate the application process. Abbott makes Kaletra (lopinavir/ritonavir) and Norvir (ritonavir).

Bridges to Access

Shruti Kalra — Thu, 13 Aug 2009 02:45:49 +0000

Bridges to Access, GlaxoSmithKline’s patient assistance program for non-oncology medicines, provides GSK prescription medicines to eligible low-income patients without prescription drug benefits.